Cuadra, Baby Boy .

HRN: 27-66-00  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2025
AMPICILLIN 250MG (VIAL)
08/14/2025
08/21/2025
IV
70mg
IV
PSNB
Remove - Pending Acceptance
08/14/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
08/14/2025
08/21/2025
IV
7mg
Q36
Psnb
Remove - Pending Acceptance
08/18/2025
CEFOTAXIME 500MG (VIAL)
08/18/2025
08/25/2025
IV
70mg
Q12H
Neonatal Pneumonia
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: